{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:45:36Z","timestamp":1748972736271},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1093\/jac\/dkx085","type":"journal-article","created":{"date-parts":[[2017,2,25]],"date-time":"2017-02-25T12:06:59Z","timestamp":1488024419000},"page":"2089-2092","source":"Crossref","is-referenced-by-count":6,"title":["Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred\u2019s experience"],"prefix":"10.1093","volume":"72","author":[{"given":"Wirawan","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg I.","family":"Snell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn J.","family":"Levvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen P.","family":"Westall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Orla","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Ivulich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin Fen","family":"Neoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C. M.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"key\n\t\t\t\t20170616061036_dkx085-B1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.trre.2007.12.007","article-title":"Fungal infections after lung transplantation","volume":"22","year":"2008","journal-title":"Transplant Rev (Orlando)"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/tid.12362","article-title":"Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience","volume":"17","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/myc.12036","article-title":"Pharmacoeconomic assessment of therapy for invasive aspergillosis","volume":"56","year":"2013","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B5","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/00365548.2012.691207","article-title":"Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with aspergillus: a retrospective study of 147 patients","volume":"44","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tid.12071","article-title":"Preemptive treatment with voriconazole in lung transplant recipients","volume":"15","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1592\/phco.31.2.214","article-title":"Therapeutic drug monitoring of voriconazole and posaconazole","volume":"31","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11908-011-0220-x","article-title":"Long-term voriconazole and skin cancer: is there cause for concern?","volume":"13","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2011.051995","article-title":"Comparative clinical effectiveness of prophylactic voriconazole\/posaconazole to fluconazole\/itraconazole in patients with acute myeloid leukemia\/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period","volume":"97","year":"2012","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B13","first-page":"99","volume-title":"Clinical Transplants 2014","year":"2015"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ctr.12516","article-title":"Epidemiology of invasive fungal infections in lung transplant recipients on long-term azole antifungal prophylaxis","volume":"29","year":"2015","journal-title":"Clin Transplant"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B18","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1128\/AAC.00424-16","article-title":"Pharmacokinetics of posaconazole suspension in lung transplant patients with and without cystic fibrosis","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B19","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1093\/jac\/dkw322","article-title":"Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and\/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170616061036_dkx085-B20","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1128\/AAC.04035-14","article-title":"Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/7\/2089\/17723453\/dkx085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T20:05:15Z","timestamp":1503605115000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkx085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,3,22]]},"published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx085","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,22]]}}}